Evidence map›Paper›PMID 27198196›Full record

ArticleNature communications2016

Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.

Atsushi Kadowaki, Sachiko Miyake, Ryoko Saga, Asako Chiba, Hideki Mochizuki, Takashi Yamamura

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03766321 (Interplay Between Gut Microbiota and Adaptive Immunity in Amyotrophic Lateral Sclerosis), which is not on this map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03766321 naactive not recruitingnot on this mapstarted 2020, after this paper: background citation

Interplay Between Gut Microbiota and Adaptive Immunity in Amyotrophic Lateral Sclerosis: a Clinical Trial

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria di ModenaRan2020 to 2025Enrolled42ConditionsAmyotrophic Lateral SclerosisArmsFecal microbiota transplantation, Placebo
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. LAG-3Immunology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. LAG-3-An incompletely understood target in cancer therapy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  16. Association betweenInternational journal of molecular sciences · 2022
    Article
  17. Review
  18. Article
  19. Fewer LAG-3Journal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Atsushi KadowakiDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Tokyo 187-8502, Japan.
Sachiko MiyakeDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Tokyo 187-8502, Japan.
Ryoko SagaDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Tokyo 187-8502, Japan.
Asako ChibaDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Tokyo 187-8502, Japan.
Hideki MochizukiDepartment of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita 565-0871, Japan.ORCID 0000-0002-0874-7542
Takashi YamamuraDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Tokyo 187-8502, Japan.
National Center of Neurology and Psychiatry · JPJuntendo University · JPMuseum of Japanese Art Yamato Bunkakan · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut environment has been found to significantly influence autoimmune diseases such as multiple sclerosis; however, immune cell mechanisms are unclear. Here we show that the gut epithelium of myelin oligodendrocyte glycoprotein(35-55)-specific T-cell receptor transgenic mice contains environmental stimuli-induced intraepithelial lymphocytes (IELs) that inhibit experimental autoimmune encephalomyelitis on transfer. These cells express surface markers phenotypical of 'induced' IELs, have a TH17-like profile and infiltrate the central nervous system (CNS). They constitutively express Ctla4 and Tgfb1 and markedly upregulate Lag3 expression in the CNS, thereby inhibiting inflammation. We also demonstrate the suppressive capability of CD4(+) IELs with alternative antigen specificities, their proliferation in response to gut-derived antigens and contribution of the microbiota and dietary aryl hydrocarbon receptor ligands to their induction. Thus, the gut environment favours the generation of autoreactive CD4(+) T cells with unique regulatory functions, potentially important for preventing CNS autoimmunity.

Indexed as

Adoptive TransferAnimalsAntigens, CDBasic Helix-Loop-Helix ProteinsCD4-Positive T-LymphocytesCentral Nervous SystemCTLA-4 AntigenEncephalomyelitis, Autoimmune, ExperimentalGastrointestinal MicrobiomeIntestinal MucosaIntraepithelial LymphocytesLymph NodesLymphocyte Activation Gene 3 ProteinMiceMice, TransgenicMyelin-Oligodendrocyte GlycoproteinAhr protein, mouseAntigens, CDBasic Helix-Loop-Helix ProteinsCTLA-4 AntigenLag3 protein, mouseLymphocyte Activation Gene 3 ProteinMog protein, mouseMyelin-Oligodendrocyte GlycoproteinReceptors, Aryl HydrocarbonTransforming Growth Factor beta

Identifiers

PMID27198196
PMCPMC4876462
OpenAlexW2395806598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.